General Dermatology

From acne to psoriasis, nutrition influences disease severity, treatment response, and patient quality of life.

Advances in atopic dermatitis research could bring longer-lasting biologics and improved treatment adherence.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about upadacitinib for vitiligo, the commercial release of roflumilast for pediatric AD, a recap of the top pearls at Fall Clinical 2025, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Christopher Bunick, MD, PhD, emphasizes how dermatologists can improve outcomes through vigilant skin exams and collaborative care with oncology teams.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Onco-dermatology enhances patient care and quality of life by addressing skin toxicities in breast cancer treatments through expert management and collaboration.

CURE spoke with experts about possible dermatologic adverse effects faced by patients with breast cancer.

Dermatology Times is looking back on the top stories in dermatology from the month of October.

Updated FDA policies eliminate many comparative efficacy trials, reducing biosimilar development time and cost by relying more on analytical testing.

La-Urshalar Brock, FNP-BC, CNM, describes tactics for managing dermatologic AEs in patients with breast cancer as part of a multidisciplinary care team.

Learn more about the in-depth topics covered in the October 2025 print issue of Dermatology Times.

Explore the intricate relationship between rheumatologic dermatology and breast cancer, highlighting diagnostic challenges and treatment insights for dermatologists.

Explore a personal journey of resilience and proactive choices in the fight against breast cancer during Breast Cancer Awareness Month.

Peter Lio, MD, believes that collaboration between science and industry is vital for translating research into meaningful patient benefits.

Discover essential dermatology insights from experts at the Fall Clinical Conference 2025, featuring innovative treatment tips and patient care strategies.

Emerging skin treatments present unique clinical challenges that must be anticipated by clinicians.

Click through this slideshow to see what faces familiar to Dermatology Times will be on the speaker stand at Fall Clinical this week.

Surface keratin 1 has emerged as a promising target in triple-negative breast cancer, bridging dermatology and oncology for innovative treatments.

Fall Clinical 2025 continues its tradition of blending cutting-edge science with practical insights for the modern dermatologist.

New evidence supports biologic agents as precise, better-tolerated alternatives to systemic immunosuppressants for life-threatening dermatologic emergencies.

This October, discover how dermatology and oncology collaborate to enhance breast cancer care and support patients through innovative therapies and teamwork.

Explore the intricate link between dermatology and psychiatric disorders, revealing how mental health impacts skin conditions and treatment approaches.

Azitra reveals promising preclinical results for ATR-01, a novel treatment targeting ichthyosis vulgaris, paving the way for future clinical trials.